(Q37315409)

19 August 2017

1 reference

title

Place of HSCT in treatment of childhood AML. (English)

1 reference

19 August 2017

T Klingebiel

1

1 reference

19 August 2017

D Reinhardt

series ordinal

2

1 reference

19 August 2017

P Bader

series ordinal

3

1 reference

19 August 2017

EBMT Paediatric Diseases Working Party

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Bone Marrow Transplantation

19 August 2017

published in

1 reference

19 August 2017

volume

42 Suppl 2

1 reference

19 August 2017

page(s)

S7-9

1 reference

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Bone marrow transplantation for paediatric AML in first remission: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Definition of a standard-risk group in children with AML

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

The haploidentical option for high-risk haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.276

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.276

1 reference

19 August 2017

1 reference